AbCellera Biologics Inc. ABCL Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Research fees | $31.26M+14.9% | $27.21M+12.0% | $24.29M+11.6% | $21.76M+5.8% | $20.58M-21.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AbCellera Biologics Inc. break its business down?
- AbCellera Biologics Inc. (ABCL) reports total revenue by product across 2 parts — Licensing and royalty revenue and Research fees. Each is extracted from the segment footnotes and tracked over time.
- Where does AbCellera Biologics Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AbCellera Biologics Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
